Indications and uses
1.1 Temporary relief of fluid retention 1.2 Tissue swelling and related disconforts
1.1 Temporary relief of fluid retention 1.2 Tissue swelling and related disconforts
Adults: 20 drops in a little water, 2 times per day for an avarage of two months. Stop use and ask a doctor if symptoms persist more than 5 days. Administration may very according to individual needs. GUNA-DIUR may be used together with other homeopthic medicines.
16.1. NDC 17089-260-18 Oral Solution/Drops 30 mL 16.2. Store at 20-25°C (68-77° F). Excursions permitted between 15°-30°C (59°-86°F).
1.1 Temporary relief of fluid retention
1.2 Tissue swelling and related disconforts
Adults: 20 drops in a little water, 2 times per day for an avarage of two months.
Stop use and ask a doctor if symptoms persist more than 5 days.
Administration may very according to individual needs.
GUNA-DIUR may be used together with other homeopthic medicines.
3.1. 30 ml Bottle dropper container contains:
Active ingredients: Amiloride 4X 0.006 ml, Apis Mellifica 2X 0.626 ml, Berberis Vulgaris T 0.314 ml, Hydrochlorothiazide 4X 0.006 ml, Hypophysis 12X 6.314 ml, Mouse-Ear Hawkweed T 6.314 ml, Solidago Virgaurea T 0.314 ml, Spironolactone 4X 0.006 ml.
Inactive Ingredient: Ethylic Alcohol 30%
4.1. There is no history of hypersensitivity to GUNA-DIUR. However, do not use if you are hypersensitive to any of the active ingredients of Guna-Diur.
5.1. GUNA-DIUR is contraindicated in patients with anuria and in patients with a history of hypersensitivity to Spironolactone, Amiloride, or Hydrocholorthiazide.
5.2. Use with caution in patients taking diuretic medications.
5.3 Keep out of reach of children.
6.1. None known (see CONTRAINDICATIONS for hypersensitivity information).
7.1. None Known
8.1.
Pregnancy: Pregnancy category C. Animal reproduction studies have not been conducted with GUNA-DIUR. GUNA®- DIUR should not be given to a pregnant woman.
8.2.
Lactation: It is not known whether any of the ingredients in GUNA- DIUR are secreted in human milk. However, since many drugs are secreted in human milk, caution should be exercised when GUNA- DIUR is administered to a nursing woman.
8.3.
Pediatric use: Safety and effectiveness in pediatric patients have not been established.
8.4.
Geriatric use: No restrictions.
9.1. No Known.
10.1. No Known.
11. 1 GUNA-DIUR is a homeopathic medicine indicated for the temporary relief of fluid retention, tissue swelling and related disconforts.
12.1. GUNA-DIUR exerts a diuretic effect. This is based on homeopthica Materia Medica and homeopathic principles.
12.2. Pharmacodynamics
Not applicable to homeopthic medicinal products.
12.3. Pharmacokinetics
Not applicable to homeopthic medicinal products.
13.1. Not available.
14.1. GUNA-DIUR efficacy is not supported by clinical studies. It is based on homeopathic Materia Medica and scientific literature.
15.1. H.H. Reckeweg. Homeopathic Materia Medica. Aurelia Verlag.
15.2. Boericke, William, Materia Medica with Reperatory, 1927, ninth edition
16.1. NDC 17089-260-18 Oral Solution/Drops 30 mL
16.2. Store at 20-25°C (68-77° F). Excursions permitted between 15°-30°C (59°-86°F).
17.1. Patients should be informed about Homeopathy and the main differences with conventional clinical approaches.
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17089-260-18 | GUNA-DIUR | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 2 | |
| 17089-260-18 | GUNA-DIUR | 30 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 30 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17089-260 | GUNA-DIUR (AMILORIDE - APIS MELLIFERA - BERBERIS VULGARIS FRUIT - HIERACIUM PILOSELLA FLOWERING TOP - HYDROCHLOROTHIAZIDE - SOLIDAGO VIRGAUREA FLOWERING TOP - SPIRONOLACTONE - SUS SCROFA PITUITARY GLAND -) SOLUTION/ DROPS [GUNA SPA] | 2 | Current NDC, Legacy NDC, 2 package rows | 20190405_3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AMILORIDE | ACTIVE INGREDIENT | 7DZO8EB0Z3 | 1 | |
| APIS MELLIFERA | ACTIVE INGREDIENT | 7S82P3R43Z | 1 | |
| BERBERIS VULGARIS FRUIT | ACTIVE INGREDIENT | 6XEF22AHC3 | 1 | |
| HIERACIUM PILOSELLA FLOWERING TOP | ACTIVE INGREDIENT | 08A7Y81S1P | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | 1 | |
| SOLIDAGO VIRGAUREA FLOWERING TOP | ACTIVE INGREDIENT | 5405K23S50 | 1 | |
| SPIRONOLACTONE | ACTIVE INGREDIENT | 27O7W4T232 | 1 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE INGREDIENT | E8S87O660T | 1 | |
| AMILORIDE | ACTIVE MOIETY | 7DZO8EB0Z3 | 1 | |
| APIS MELLIFERA | ACTIVE MOIETY | 7S82P3R43Z | 1 | |
| BERBERIS VULGARIS FRUIT | ACTIVE MOIETY | 6XEF22AHC3 | 1 | |
| HIERACIUM PILOSELLA FLOWERING TOP | ACTIVE MOIETY | 08A7Y81S1P | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | 1 | |
| SOLIDAGO VIRGAUREA FLOWERING TOP | ACTIVE MOIETY | 5405K23S50 | 1 | |
| SPIRONOLACTONE | ACTIVE MOIETY | 27O7W4T232 | 1 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE MOIETY | E8S87O660T | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17089-260 | 17089-260-18 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| AMILORIDE | 7DZO8EB0Z3 | ACTIB |
| APIS MELLIFERA | 7S82P3R43Z | ACTIB |
| BERBERIS VULGARIS FRUIT | 6XEF22AHC3 | ACTIB |
| HYDROCHLOROTHIAZIDE | 0J48LPH2TH | ACTIB |
| SUS SCROFA PITUITARY GLAND | E8S87O660T | ACTIB |
| HIERACIUM PILOSELLA FLOWERING TOP | 08A7Y81S1P | ACTIB |
| SOLIDAGO VIRGAUREA FLOWERING TOP | 5405K23S50 | ACTIB |
| SPIRONOLACTONE | 27O7W4T232 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GUNA-DIUR | AMILORIDE - APIS MELLIFERA - BERBERIS VULGARIS FRUIT - HIERACIUM PILOSELLA FLOWERING TOP - HYDROCHLOROTHIAZIDE - SOLIDAGO VIRGAUREA FLOWERING TOP - SPIRONOLACTONE - SUS SCROFA PITUITARY GLAND - | Guna spa | 3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2 | 2018-12-21 | Warnings, Adverse reactions | 17089-260-18 17089-260 17089026018 7e7c2115-72fe-9ca5-e053-2a91aa0ae101 3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.